An evidence-based managed care budget impact model shows that incorporating TSI testing into existing Graves%u2019 disease hyperthyroidism diagnostic algorithms reduces costs and shortens time to diagnosis.
Amy McKee, PhD
Advertisement
Articles by Amy McKee, PhD
Advertisement
Latest Updated Articles
- TSI Assay Utilization: Impact on Costs of Graves' Hyperthyroidism Diagnosis
Published: January 16th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
2
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
3
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
4
Revumenib Granted FDA Approval for R/R NPM1-Mutated AML
5
